John C. McCormickManaging DirectorMr. McCormick’s primary responsibilities are in private equity investing and as a senior member of the HealthpointCapital research team. He is currently a member of the Board of Directors of Scient'x, S.A. He has been publishing regularly on the orthopedics industry and medical technology for six years with principal areas of focus being spine surgery, sports medicine and capital markets analysis. Prior to the formation of HealthpointCapital, Mr. McCormick spent six years in the private equity field as a Principal at BPI Capital Partners, LLC; he was an Associate with Baker Nye, LP, a $600 million private investment fund. At his prior firms, he held senior operating roles at portfolio companies. Mr. McCormick started his career as a macroeconomic and financial analyst at the World Bank in Washington, DC. He is a member of the Board of Associates of the Whitehead institute of Biomedical Research and a trustee of the International Center for Disabilities. Mr. McCormick received a BSc. with honors from London School of Economics and an M.B.A. from the M.I.T. Sloan School of Management. Recent Articles by John McCormick
Integra Acquries IST SEP 14, 2009Early this morning, Integra LifeSciences anounced that it is has acquired the assets of Innovative Spinal Technologies, Inc. (IST) for $9.25 million in cash. Although IST had a little over $2 million of revenue last year, the Company shut its... more Industry Private Placements Alive and Well AUG 26, 2009Last week's $75 million private placement in Arthrocare (ARTC.PK) was not a one off event. It was more like a sign of the times. Private placements are investments in a company where the investor is a small group of chosen... more CMS Rate Increase a Positive for Spine and Ortho AUG 3, 2009Late Friday afternoon, CMS issued their final rule for FY2010 for inpatient reimbursement rates. When we reviewed specific areas of spine, the rule turned out to be a boost compared to their April proposal. Spine reimbursement rates were finalized at... more ConforMIS Raises $50 Million JUL 14, 2009Custom knee resurfacing implant developer ConforMIS announced that it has raised $50 million from a group of private equity firms and non-US government investment funds. This 2004 start-up has steadily developed a technology that turns patient imaging data into custom... more Ray Elliott Finds a New Home JUN 25, 2009This morning cardio giant, Boston Scientific, Inc. announced that former Zimmer Chief Executive Ray Elliott will become their new President and Chief Executive Officer. Ray Elliott is famous in our industry for having led Zimmer 10 years first as President... more |
|
|